|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1995;60:1394
© 1995 The Society of Thoracic Surgeons
Department of Melanoma/Sarcoma Medical Oncology and, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030
| The first 20% of the full text of this article appears below. |
See also page 1390.
Sarcomas of bone and soft tissue frequently metastasize to the lungs and infrequently involve other organs. Moreover, when pulmonary metastases develop, the majority of patients ultimately succumb to their disease despite resection, because of development of more pulmonary metastases. Finding a way to eliminate pulmonary disease in patients with sarcomas would therefore significantly improve the prognosis of this group of tumors. Results of systemic chemotherapy for
Related Article
Ann. Thorac. Surg. 1995 60: 1390-1394.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |